Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models.

Wongjarupong N, Negron-Ocasio GM, Chaiteerakij R, Addissie BD, Mohamed EA, Mara KC, Harmsen WS, Theobald JP, Peters BE, Balsanek JG, Ward MM, Giama NH, Venkatesh SK, Harnois DM, Charlton MR, Yamada H, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR.

World J Gastroenterol. 2018 Mar 28;24(12):1321-1331. doi: 10.3748/wjg.v24.i12.1321.

2.

Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.

Cornec D, Kabat BF, Mills JR, Cheu M, Hummel AM, Schroeder DR, Cascino MD, Brunetta P, Murray DL, Snyder MR, Fervenza F, Hoffman GS, Kallenberg CGM, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Barnidge DR, Specks U.

Rheumatology (Oxford). 2018 Apr 1;57(4):639-650. doi: 10.1093/rheumatology/kex484.

PMID:
29340623
3.

Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM.

Martinez-Thompson JM, Snyder MR, Ettore M, McKeon A, Pittock SJ, Roforth MM, Mandrekar J, Mauermann ML, Taylor BV, Dyck PJB, Windebank AJ, Klein CJ.

Muscle Nerve. 2018 Jun;57(6):1000-1005. doi: 10.1002/mus.26051. Epub 2018 Jan 26.

PMID:
29272035
4.

Undetectable negative tissue transglutaminase IgA antibodies predict mucosal healing in treated coeliac disease patients.

Fang H, King KS, Larson JJ, Snyder MR, Wu TT, Gandhi MJ, Murray JA.

Aliment Pharmacol Ther. 2017 Oct;46(7):681-687. doi: 10.1111/apt.14250. Epub 2017 Aug 7.

PMID:
28782118
5.

Measuring and Interpreting Serum AAT Concentration.

Donato LJ, Snyder MR, Greene DN.

Methods Mol Biol. 2017;1639:21-32. doi: 10.1007/978-1-4939-7163-3_3.

PMID:
28752443
6.

Blood type, ABO genetic variants, and ovarian cancer survival.

Cozzi GD, Levinson RT, Toole H, Snyder MR, Deng A, Crispens MA, Khabele D, Beeghly-Fadiel A.

PLoS One. 2017 Apr 27;12(4):e0175119. doi: 10.1371/journal.pone.0175119. eCollection 2017. Erratum in: PLoS One. 2017 May 30;12 (5):e0178965.

7.

Lack of Utility of Anti-tTG IgG to Diagnose Celiac Disease When Anti-tTG IgA Is Negative.

Absah I, Rishi AR, Gebrail R, Snyder MR, Murray JA.

J Pediatr Gastroenterol Nutr. 2017 May;64(5):726-729. doi: 10.1097/MPG.0000000000001351.

PMID:
28437323
8.

Genetic patterns across an invasion's history: a test of change versus stasis for the Eurasian round goby in North America.

Snyder MR, Stepien CA.

Mol Ecol. 2017 Feb;26(4):1075-1090. doi: 10.1111/mec.13997. Epub 2017 Jan 27.

PMID:
28029720
9.

Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.

Kohlhagen MC, Barnidge DR, Mills JR, Stoner J, Gurtner KM, Liptac AM, Lofgren DI, Vanderboom PM, Dispenzieri A, Katzmann JA, Willrich MA, Snyder MR, Murray DL.

Clin Chem. 2016 Oct;62(10):1345-52. doi: 10.1373/clinchem.2015.253781. Epub 2016 Aug 11.

10.

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis.

Mills JR, Cornec D, Dasari S, Ladwig PM, Hummel AM, Cheu M, Murray DL, Willrich MA, Snyder MR, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Specks U, Barnidge DR.

Anal Chem. 2016 Jun 21;88(12):6317-25. doi: 10.1021/acs.analchem.6b00544. Epub 2016 Jun 3.

11.

Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.

Fussner LA, Hummel AM, Schroeder DR, Silva F, Cartin-Ceba R, Snyder MR, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, William St Clair E, Tchao NK, Stone JH, Specks U; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.

Arthritis Rheumatol. 2016 Jul;68(7):1700-10. doi: 10.1002/art.39637.

12.

Determination of B-Cell Epitopes in Patients with Celiac Disease: Peptide Microarrays.

Choung RS, Marietta EV, Van Dyke CT, Brantner TL, Rajasekaran J, Pasricha PJ, Wang T, Bei K, Krishna K, Krishnamurthy HK, Snyder MR, Jayaraman V, Murray JA.

PLoS One. 2016 Jan 29;11(1):e0147777. doi: 10.1371/journal.pone.0147777. eCollection 2016.

13.

Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation.

Willrich MA, Ladwig PM, Andreguetto BD, Barnidge DR, Murray DL, Katzmann JA, Snyder MR.

Clin Chem Lab Med. 2016 Jun 1;54(6):1085-93. doi: 10.1515/cclm-2015-1023.

PMID:
26812875
14.

Celiac disease: advances in diagnosis.

Snyder MR, Murray JA.

Expert Rev Clin Immunol. 2016;12(4):449-63. doi: 10.1586/1744666X.2016.1130625. Epub 2016 Jan 19. Review.

PMID:
26654883
15.

SERPINA1 Full-Gene Sequencing Identifies Rare Mutations Not Detected in Targeted Mutation Analysis.

Graham RP, Dina MA, Howe SC, Butz ML, Willkomm KS, Murray DL, Snyder MR, Rumilla KM, Halling KC, Highsmith WE Jr.

J Mol Diagn. 2015 Nov;17(6):689-94. doi: 10.1016/j.jmoldx.2015.07.002. Epub 2015 Aug 28.

PMID:
26321041
16.

Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles.

Donato LJ, Karras RM, Katzmann JA, Murray DL, Snyder MR.

Respir Res. 2015 Aug 5;16:96. doi: 10.1186/s12931-015-0256-9.

17.

Quantitation of infliximab using clonotypic peptides and selective reaction monitoring by LC-MS/MS.

Willrich MA, Murray DL, Barnidge DR, Ladwig PM, Snyder MR.

Int Immunopharmacol. 2015 Sep;28(1):513-20. doi: 10.1016/j.intimp.2015.07.007. Epub 2015 Jul 25.

PMID:
26210595
18.

Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation.

Chaiteerakij R, Zhang X, Addissie BD, Mohamed EA, Harmsen WS, Theobald PJ, Peters BE, Balsanek JG, Ward MM, Giama NH, Moser CD, Oseini AM, Umeda N, Venkatesh S, Harnois DM, Charlton MR, Yamada H, Satomura S, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR.

Liver Transpl. 2015 May;21(5):599-606. doi: 10.1002/lt.24117.

19.

Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.

Katzmann JA, Willrich MA, Kohlhagen MC, Kyle RA, Murray DL, Snyder MR, Rajkumar SV, Dispenzieri A.

Clin Chem. 2015 Feb;61(2):360-7. doi: 10.1373/clinchem.2014.231985. Epub 2014 Dec 1.

20.

Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases.

Willrich MA, Murray DL, Snyder MR.

Transl Res. 2015 Feb;165(2):270-82. doi: 10.1016/j.trsl.2014.09.006. Epub 2014 Sep 22. Review.

PMID:
25305470
21.

Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometry.

Barnidge DR, Dasari S, Ramirez-Alvarado M, Fontan A, Willrich MA, Tschumper RC, Jelinek DF, Snyder MR, Dispenzieri A, Katzmann JA, Murray DL.

J Proteome Res. 2014 Nov 7;13(11):5198-205. doi: 10.1021/pr5005967. Epub 2014 Aug 26.

PMID:
25134970
22.

Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography--tandem mass spectrometry.

Ladwig PM, Barnidge DR, Snyder MR, Katzmann JA, Murray DL.

Clin Chem. 2014 Aug;60(8):1080-8. doi: 10.1373/clinchem.2014.222208. Epub 2014 May 5.

23.

Monitoring M-proteins in patients with multiple myeloma using heavy-chain variable region clonotypic peptides and LC-MS/MS.

Barnidge DR, Tschumper RC, Theis JD, Snyder MR, Jelinek DF, Katzmann JA, Dispenzieri A, Murray DL.

J Proteome Res. 2014 Apr 4;13(4):1905-10. doi: 10.1021/pr5000544. Epub 2014 Mar 5.

PMID:
24552626
24.

Vitreoretinal lymphoma versus uveitis: cytokine profile and correlations.

Caraballo JN, Snyder MR, Johnston PB, O Neill BP, Raja H, Balsanek JG, Peters BE, Pulido JS.

Ocul Immunol Inflamm. 2014 Feb;22(1):34-41. doi: 10.3109/09273948.2012.752507.

PMID:
24490677
25.

Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy.

Barnidge DR, Dasari S, Botz CM, Murray DH, Snyder MR, Katzmann JA, Dispenzieri A, Murray DL.

J Proteome Res. 2014 Mar 7;13(3):1419-27. doi: 10.1021/pr400985k. Epub 2014 Feb 11.

PMID:
24467232
26.

Dexamethasone levels predict cortisol response after infant cardiopulmonary bypass.

Crow SS, Oliver WC Jr, Kiefer JA, Snyder MR, Dearani JA, Li Z, Burkhart HM.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):475-81. doi: 10.1016/j.jtcvs.2013.09.023. Epub 2013 Nov 8.

27.

Lack of evidence for intrathecal tryptase synthesis in patients with systemic mastocytosis.

Smith JH, Snyder MR, Weiler CR, Cutrer FM, Butterfield JH.

J Allergy Clin Immunol. 2013 Oct;132(4):996-7. doi: 10.1016/j.jaci.2013.04.060. Epub 2013 Jun 27. No abstract available.

PMID:
23810768
28.

Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma.

Raja H, Snyder MR, Johnston PB, O'Neill BP, Caraballo JN, Balsanek JG, Peters BE, Decker PA, Pulido JS.

PLoS One. 2013 Jun 4;8(6):e65627. doi: 10.1371/journal.pone.0065627. Print 2013.

29.

Methodological issues in clinical drug development for essential tremor.

Carranza MA, Snyder MR, Elble RJ, Boutzoukas AE, Zesiewicz TA.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-68-402-1. doi: 10.7916/D8P55M7F. Epub 2012 Aug 6.

30.
31.

Laboratory persistence and clinical progression of small monoclonal abnormalities.

Murray DL, Seningen JL, Dispenzieri A, Snyder MR, Kyle RA, Rajkumar SV, Katzmann JA.

Am J Clin Pathol. 2012 Oct;138(4):609-13.

32.

Reference and interpretive ranges for α(1)-antitrypsin quantitation by phenotype in adult and pediatric populations.

Donato LJ, Jenkins SM, Smith C, Katzmann JA, Snyder MR.

Am J Clin Pathol. 2012 Sep;138(3):398-405. doi: 10.1309/AJCPMEEJK32ACYFP.

PMID:
22912357
33.

Analytical and clinical comparison of anti-CCP assays with rheumatoid factor for the diagnosis of rheumatoid arthritis.

Block DR, Jenkins SM, Dalenberg DA, Balsanek JG, Snyder MR, Saenger AK.

Clin Chim Acta. 2012 Jun 14;413(11-12):1015-7. doi: 10.1016/j.cca.2012.02.002. Epub 2012 Feb 14.

PMID:
22353668
34.

A challenging diagnosis of alpha-1-antitrypsin deficiency: identification of a patient with a novel F/Null phenotype.

Ringenbach MR, Banta E, Snyder MR, Craig TJ, Ishmael FT.

Allergy Asthma Clin Immunol. 2011 Nov 13;7(1):18. doi: 10.1186/1710-1492-7-18.

35.

Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies.

Katzmann JA, Snyder MR, Rajkumar SV, Kyle RA, Therneau TM, Benson JT, Dispenzieri A.

Clin Chem. 2011 Dec;57(12):1687-92. doi: 10.1373/clinchem.2011.171314. Epub 2011 Oct 6.

36.

Simultaneous phenotyping and quantification of α-1-antitrypsin by liquid chromatography-tandem mass spectrometry.

Chen Y, Snyder MR, Zhu Y, Tostrud LJ, Benson LM, Katzmann JA, Bergen HR 3rd.

Clin Chem. 2011 Aug;57(8):1161-8. doi: 10.1373/clinchem.2011.163006. Epub 2011 Jun 2.

37.

Immune evaluation and vaccine responses in Down syndrome: evidence of immunodeficiency?

Joshi AY, Abraham RS, Snyder MR, Boyce TG.

Vaccine. 2011 Jul 12;29(31):5040-6. doi: 10.1016/j.vaccine.2011.04.060. Epub 2011 May 17.

38.

Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody.

Rashtak S, Rashtak S, Snyder MR, Pittock SJ, Wu TT, Gandhi MJ, Murray JA.

J Neuroimmunol. 2011 Jan;230(1-2):130-4. doi: 10.1016/j.jneuroim.2010.09.024. Epub 2010 Nov 6.

39.

Specificity of serum and urine protein electrophoresis for the diagnosis of monoclonal gammopathies.

Katzmann JA, Stankowski-Drengler TJ, Kyle RA, Karen SL, Snyder MR, Lust JA, Dispenzieri A.

Clin Chem. 2010 Dec;56(12):1899-900. doi: 10.1373/clinchem.2010.152280. Epub 2010 Sep 15. No abstract available.

40.

Discordant alpha-1 antitrypsin phenotype and genotype results in a liver transplant patient.

Hackbarth JS, Tostrud LJ, Rumilla KM, Krowka MJ, Snyder MR.

Clin Chim Acta. 2010 Aug 5;411(15-16):1146-8. doi: 10.1016/j.cca.2010.03.038. Epub 2010 Mar 31. No abstract available.

PMID:
20362565
41.

Comparison of two ventilatory strategies in elderly patients undergoing major abdominal surgery.

Weingarten TN, Whalen FX, Warner DO, Gajic O, Schears GJ, Snyder MR, Schroeder DR, Sprung J.

Br J Anaesth. 2010 Jan;104(1):16-22. doi: 10.1093/bja/aep319.

42.

Autoantibodies and the risk of cardiovascular events.

Liang KP, Kremers HM, Crowson CS, Snyder MR, Therneau TM, Roger VL, Gabriel SE.

J Rheumatol. 2009 Nov;36(11):2462-9. doi: 10.3899/jrheum.090188. Epub 2009 Oct 15.

43.

Quantitation of serum monoclonal proteins: relationship between agarose gel electrophoresis and immunonephelometry.

Murray DL, Ryu E, Snyder MR, Katzmann JA.

Clin Chem. 2009 Aug;55(8):1523-9. doi: 10.1373/clinchem.2009.124461. Epub 2009 Jun 11.

44.

Screening panels for detection of monoclonal gammopathies.

Katzmann JA, Kyle RA, Benson J, Larson DR, Snyder MR, Lust JA, Rajkumar SV, Dispenzieri A.

Clin Chem. 2009 Aug;55(8):1517-22. doi: 10.1373/clinchem.2009.126664. Epub 2009 Jun 11.

45.

Quantification of urinary light chains.

Snyder MR, Clark R, Bryant SC, Katzmann JA.

Clin Chem. 2008 Oct;54(10):1744-6. doi: 10.1373/clinchem.2008.107599. No abstract available.

46.

Pharmacokinetics of intravitreal ranibizumab (Lucentis).

Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ.

Ophthalmology. 2007 Dec;114(12):2179-82.

PMID:
18054637
47.

Pharmacokinetics of intravitreal bevacizumab (Avastin).

Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ.

Ophthalmology. 2007 May;114(5):855-9.

PMID:
17467524
48.

Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.

Katzmann JA, Dispenzieri A, Kyle RA, Snyder MR, Plevak MF, Larson DR, Abraham RS, Lust JA, Melton LJ 3rd, Rajkumar SV.

Mayo Clin Proc. 2006 Dec;81(12):1575-8.

PMID:
17165636
49.

Diagnosis of alpha-1-antitrypsin deficiency: An algorithm of quantification, genotyping, and phenotyping.

Snyder MR, Katzmann JA, Butz ML, Wiley C, Yang P, Dawson DB, Halling KC, Highsmith WE, Thibodeau SN.

Clin Chem. 2006 Dec;52(12):2236-42. Epub 2006 Oct 19. Erratum in: Clin Chem. 2007 Sep;53(9):1724. Wiley, Carmen [added].

50.

Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing.

Bakri SJ, Snyder MR, Pulido JS, McCannel CA, Weiss WT, Singh RJ.

Retina. 2006 May-Jun;26(5):519-22.

PMID:
16770257

Supplemental Content

Loading ...
Support Center